Risk-Based Post Market Surveillance Programme
Conducts a risk-based post market surveillance (PMS)
programme for the monitoring and quality assessment
of selected medicines. The MQCSD coordinates the
annual selection of medicines of regional importance
through risk-based criteria developed for the
programme and the proposed schedule, with input
from key stakeholders such as the focal points of the
national regulatory authorities/procurement bodies.
The focal points collect and submit samples to the
MQCSD for testing according to the schedule. The
results are issued in Certificates of Analysis to the
national regulatory authorities/procurement bodies for
decision-making, action and/or reporting to national,
regional or international monitoring systems.